The funding from the Walloon Region will enable Univercells to start developing a manufacturing platform aimed at driving down costs of biosimilars manufacturing. / read more /
FDA is monitoring the IV fluid shortage occurring due to Hurricane Maria and is asking companies to submit data for the possibility of extending expiration dates. / read more /
The company will invest $139 million in sterile manufacturing technology at its facility in Ballytivnan, Sligo, Ireland to support the growth of its oncology pipeline. / read more /
Clover Biopharmaceuticals will use GE’s FlexFactory biomanufacturing platform with single-use bioreactors to produce innovative and biosimilar fusion protein products in China. / read more /
Orbis Biosciences’ Optimµm Platform delivers microparticulate dosage forms with controlled-release and taste-masked properties in a single manufacturing step. / read more /
Graham Reynolds from West Pharmaceutical Services shares insights on key considerations when developing a biologic drug product in a prefilled syringe. / read more /
Date: 12 – 14 March 2018 Venue: Maritim proArte Hotel, Berlin, Germany Innovative solutions to the greatest challenges in pharmaceutical development
The DDF Summit brings the most interesting studies and exciting technologies to you. This year there will be 4 dedicated streams focusing on Small Molecules, Biologics, Technology & Innovation and for the first-time Device Development. / Read more/
Vaccines—from childhood and influenza immunizations, to epidemic prevention, to cancer and therapeutic treatments—present unique development challenges. In this Vaccine and Manufacturing eBook, the editors explore development and manufacturing options to make vaccines more accessible.
